Shortage of penicillin G: Impact on antibiotic prescribing at a US tertiary care centre

International Journal of Antimicrobial Agents

Volumn 21, Issue 5, 2003, Pages 484-487

  Harbarth, Stephan ^a,b   Gundlapalli, Adi V ^a   Stockdale, William ^a   Samore, Matthew H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antibiotics; Drug industry; Health policy; Penicillin G supply; United States

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; PENICILLIN G;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUSTRY; DRUG UTILIZATION; FEMALE; GESTATION PERIOD; HEALTH CARE POLICY; HEALTH CENTER; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NONHUMAN; OBSTETRICS; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0037404626     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00003-7     Document Type: Article

References (11)

1. Kunin C.M. Resistance to antimicrobial drugs - a worldwide calamity. Ann. Intern. Med. 118:1993;557-561.
2. Lyonnet B. Il y a 50 ans, des travaux lyonnais, aujourd'hui bien oubliés, ont précédé la découverte de la pénicilline. Lyon Medical 1946; 78: 266-69.
3. Harbarth S. Antibiotic policy and penicillin-G shortage. Lancet. 355:2000;1650.
4. Evans R.S., Pestotnik S.L., Classen D.C., et al. A computer-assisted management program for antibiotics and other antiinfective agents. N. Engl. J. Med. 338:1998;232-238.
5. Kaplan E.L. Whither penicillin? A response to the question. Pediatr. Infect. Dis. J. 19:2000;177-178.
6. Schrag S.J., Whitney C.G., Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect. Control Hos. Epidemiol. 21:2000;473-483.
7. Carling P.C., Fung T., Coldiron J.S. Parenteral antibiotic use in acute-care hospitals: a standardized analysis of fourteen institutions. Clin. Infect. Dis. 29:1999;1189-1196.
8. White R.L., Friedrich L.V., Mihm L.B., Bosso J.A. Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin. Infect. Dis. 31:2000;16-23.
9. Joseph T.A., Pyati S.P., Jacobs N. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch. Pediatr. Adolescence Med. 152:1998;35-40.
10. Terrone D.A., Rinehart B.K., Einstein M.H., Britt L.B., Martin J.N. Jr., Perry K.G. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am. J. Obstet. Gynecol. 180:1999;1345-1348.
11. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347:2002;240-247.